JP4293883B2 - Deodorant composition - Google Patents
Deodorant composition Download PDFInfo
- Publication number
- JP4293883B2 JP4293883B2 JP2003366253A JP2003366253A JP4293883B2 JP 4293883 B2 JP4293883 B2 JP 4293883B2 JP 2003366253 A JP2003366253 A JP 2003366253A JP 2003366253 A JP2003366253 A JP 2003366253A JP 4293883 B2 JP4293883 B2 JP 4293883B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- deodorant composition
- skin
- component
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims description 68
- 239000002781 deodorant agent Substances 0.000 title claims description 57
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 43
- 239000000443 aerosol Substances 0.000 claims description 20
- 235000015165 citric acid Nutrition 0.000 claims description 13
- -1 chlorohydroxyaluminum Chemical compound 0.000 claims description 12
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 11
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 11
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 9
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 8
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 8
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 8
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 8
- 229930003935 flavonoid Natural products 0.000 claims description 8
- 150000002215 flavonoids Chemical class 0.000 claims description 8
- 235000017173 flavonoids Nutrition 0.000 claims description 8
- 239000001630 malic acid Substances 0.000 claims description 8
- 235000011090 malic acid Nutrition 0.000 claims description 8
- 239000011975 tartaric acid Substances 0.000 claims description 8
- 235000002906 tartaric acid Nutrition 0.000 claims description 8
- HSEYYGFJBLWFGD-UHFFFAOYSA-N 4-methylsulfanyl-2-[(2-methylsulfanylpyridine-3-carbonyl)amino]butanoic acid Chemical compound CSCCC(C(O)=O)NC(=O)C1=CC=CN=C1SC HSEYYGFJBLWFGD-UHFFFAOYSA-N 0.000 claims description 4
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 4
- 229910052726 zirconium Inorganic materials 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 2
- 230000001877 deodorizing effect Effects 0.000 description 23
- 239000000843 powder Substances 0.000 description 19
- 150000007524 organic acids Chemical class 0.000 description 17
- 229960004106 citric acid Drugs 0.000 description 12
- 235000019645 odor Nutrition 0.000 description 10
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 208000035985 Body Odor Diseases 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 210000004243 sweat Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 239000003380 propellant Substances 0.000 description 6
- 206010040904 Skin odour abnormal Diseases 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 210000001099 axilla Anatomy 0.000 description 4
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000001530 fumaric acid Substances 0.000 description 4
- 235000011087 fumaric acid Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000003749 cleanliness Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000417 fungicide Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000000873 masking effect Effects 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 229960004543 anhydrous citric acid Drugs 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- CRSOQBOWXPBRES-UHFFFAOYSA-N neopentane Chemical compound CC(C)(C)C CRSOQBOWXPBRES-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- XRYVAQQLDYTHCL-IQMFZBJNSA-N Sophoraflavanone G Natural products C1([C@H]2CC(=O)C=3C(O)=CC(O)=C(C=3O2)C[C@@H](CC=C(C)C)C(C)=C)=CC=C(O)C=C1O XRYVAQQLDYTHCL-IQMFZBJNSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229960002303 citric acid monohydrate Drugs 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 208000022196 parasitic skin disease Diseases 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N sec-butylidene Natural products CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000003009 skin protective agent Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- XRYVAQQLDYTHCL-CMJOXMDJSA-N sophoraflavanone G Chemical compound C1([C@@H]2CC(=O)C=3C(O)=CC(O)=C(C=3O2)C[C@@H](CC=C(C)C)C(C)=C)=CC=C(O)C=C1O XRYVAQQLDYTHCL-CMJOXMDJSA-N 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、デオドラント組成物に関し、更に詳しくは、防臭効果に優れ、かつその持続性にも優れた皮膚用に好適なデオドラント組成物に関する。 The present invention relates to a deodorant composition, and more particularly, to a deodorant composition suitable for skin that has an excellent deodorizing effect and excellent durability.
一般に、腋臭、汗臭、足臭などの体臭は、本人のみならず、周囲の者にとっても不快感を与えるため、体臭症者にとっては、心理的、精神的に非常に大きな負担となっている。
体臭の原因の一つとしては、汗や皮脂などの分泌物が皮膚常在菌によって分解されることにより発生するものと考えられている。
In general, body odors such as snoring, sweat odor, and foot odor are not only for the person, but also for the people around them, and this is a very psychological and mental burden for those with body odor. .
One of the causes of body odor is considered to be caused by decomposition of secretions such as sweat and sebum by skin resident bacteria.
従来より、これらの体臭を減ずるため様々な剤型の各種デオドラント剤が市販されているが、これらのほとんどは、皮膚常在菌の増殖を抑制し、汗や皮脂の分解を阻止する殺菌剤や香料を用いて臭気をマスキングするマスキング剤を用いているものである。 Conventionally, various deodorant agents of various dosage forms have been marketed to reduce these body odors, but most of them are fungicides that suppress the growth of skin resident bacteria and prevent the decomposition of sweat and sebum. It uses a masking agent that masks odor using a fragrance.
しかしながら、デオドラント組成物における殺菌剤は、その殺菌効果を有する化合物の安全性の問題が指摘されており、使用可能な種類や適用量が定められていることが多く、十分な効果を出すための使用量が制限されるという問題があった。
また、デオドラント組成物におけるマスキング剤は、体臭と匂いが混じって十分に体臭を抑えることができなかったり、逆に不快な匂いを発生させるという問題があった。
従って、これらの殺菌剤やマスキング剤に頼りすぎないデオドラント組成物が要求されているのが現状である。
However, the fungicide in the deodorant composition has been pointed out as a safety problem of the compound having the bactericidal effect, and the types and application amounts that can be used are often determined. There was a problem that the amount used was limited.
Further, the masking agent in the deodorant composition has a problem that the body odor and odor are mixed and the body odor cannot be sufficiently suppressed, or on the contrary, an unpleasant odor is generated.
Accordingly, there is a current demand for deodorant compositions that do not rely too much on these fungicides and masking agents.
一方、菌の生育条件の一つにpHが関与しているといわれており、また、腋臭の強い人の腋窩部のpHは、腋臭の弱い人に比べて相対的に高いということが見い出されている。
このため菌の繁殖を防ぎ、製品の保存性を確保するために抗菌性物質、pKa値が4〜7である2価以上の有機酸を含有する化粧料等に有用な抗菌性組成物(特許文献1参照)や、汗や皮膚表面のpHを低く保つことで皮膚常在菌の増殖を抑制させる方法として、特定の弱有機酸と有機アミン化合物の塩を組み合わせた混合物によって、汗のpHを3〜6の範囲の実質的に一定の値に保つことを特徴とする化粧用防臭性組成物(特許文献2参照)が知られている。
また、腋臭の強弱にpHが関与していることに着目し、pH3.5〜5.5において緩衝能を含有する物質を含有し、有機酸を全量溶解配合してpH3.5〜5.5としてなる防臭剤(特許文献3参照)が知られている。
更に、本願発明の目的とは異なるが、組成物の色、においの劣化防止を目的としたものとして、特定の収斂剤、懸濁剤、低揮発性の担体液体、有機酸としてクエン酸、クエン酸を少なくとも一部溶解するに足る量の溶媒、噴射剤を配合したエアゾール型の発汗防止剤組成物(特許文献4参照)が知られている。
On the other hand, it is said that pH is involved in one of the growth conditions of the fungus, and it has been found that the pH of the armpit of a person with a strong smell is relatively higher than that of a person with a weak smell. ing.
For this reason, antibacterial compositions useful for antibacterial substances, cosmetics containing divalent or higher organic acids having a pKa value of 4 to 7 in order to prevent the growth of bacteria and ensure the preservation of products (patents) As a method of suppressing the growth of skin resident bacteria by keeping the pH of sweat and the surface of the skin low, the pH of sweat is controlled by a mixture of a specific weak organic acid and a salt of an organic amine compound. A cosmetic deodorant composition (see Patent Document 2) characterized by maintaining a substantially constant value in the range of 3 to 6 is known.
In addition, paying attention to the fact that pH is involved in the strength of the bad smell, it contains a substance having a buffer capacity at pH 3.5 to 5.5, and the total amount of organic acid is dissolved and blended to pH 3.5 to 5.5. A deodorant (see Patent Document 3) is known.
Further, although different from the object of the present invention, as a purpose of preventing the deterioration of the color and odor of the composition, a specific astringent, suspension, low-volatility carrier liquid, organic acid such as citric acid, An aerosol-type antiperspirant composition containing a solvent and a propellant sufficient to dissolve at least part of an acid is known (see Patent Document 4).
しかしながら、上記特許文献1〜4に記載されるデオドラント組成物等は、防臭効果、特に防臭効果の持続性において十分満足できるものではないという課題があり、依然として効果の高い皮膚用等に好適なデオドラント組成物が望まれている。 However, the deodorant compositions and the like described in Patent Documents 1 to 4 have a problem that they are not sufficiently satisfactory in the deodorizing effect, particularly in the sustainability of the deodorizing effect, and are still suitable for use in highly effective skin. A composition is desired.
他方、クジンは、マメ科のクララの根であり、このクジン抽出物等は日本でも民間薬として、虫くだし、害虫駆除や、湿疹、寄生性皮膚病への外用剤に用いられており、殺菌作用があることはよく知られている。
このクジンを用いた抗菌・防腐剤等としては、ソフォラフラバノンGを必須成分として含有するクジンの有機溶媒抽出物を配合してなる抗菌・防腐剤、皮膚化粧料等(特許文献5及び6参照)が知られている。
On the other hand, kujin is the root of the leguminous clara, and this kujin extract is used as a folk medicine in Japan for insect pests, pest control, eczema, and external preparations for parasitic skin diseases. It is well known that it works.
As an antibacterial / preservative using this kujin, an antibacterial / preservative, skin cosmetics, etc. formed by blending an organic solvent extract of kudin containing Soforaflavanone G as an essential component (see Patent Documents 5 and 6) It has been known.
しかしながら、上記特許文献5及び6に記載される抗菌・防腐剤、皮膚化粧料等は、単にクジン抽出物からのソフォラフラバノンGの抗菌効果及びその用途等を開示するものに過ぎないものであり、本願発明とはその目的、構成等が異なるものである。
本発明は、上記従来の課題等に鑑み、これを解消しようとするものであり、防臭効果に優れ、かつその持続性にも優れた皮膚用に好適なデオドラント組成物を提供すること、更に、これらの作用効果を更に向上せしめると共に、使用上の簡便性や清潔性からエアゾール剤型としたデオドラント組成物を提供することを目的とする。 In view of the above-mentioned conventional problems and the like, the present invention is intended to solve this problem, and provides a deodorant composition suitable for skin that is excellent in deodorizing effect and excellent in its sustainability. An object of the present invention is to provide a deodorant composition that is an aerosol type from the viewpoint of ease of use and cleanliness, while further improving these effects.
本発明者らは、上記従来の課題等について、鋭意研究した結果、特定のヒドロキシカルボン酸及び/又は水溶性のアルミニウム塩と、特定の常温で液体の脂肪酸とを組み合わせることにより、上記目的の防臭効果に優れ、かつその持続性も優れた皮膚用に好適なデオドラント組成物が得られることを見い出すことにより、本発明を完成するに至ったのである。 As a result of earnest research on the above-mentioned conventional problems, the present inventors have combined the specific hydroxycarboxylic acid and / or water-soluble aluminum salt with the fatty acid that is liquid at a specific room temperature to achieve the above-mentioned deodorizing effect. The present invention has been completed by finding that a deodorant composition excellent in effect and excellent in durability can be obtained.
すなわち、本発明は、次の(1)〜(4)に存する。
(1) 下記A成分及びB成分を含有することを特徴とするデオドラント組成物。
A成分:クエン酸、リンゴ酸、酒石酸から選ばれる水溶性のヒドロキシカルボン酸0.1〜10質量%及び水溶性のアルミニウム塩5〜40質量%
B成分:イソステアリン酸1〜10質量%
(2) A成分の水溶性のアルミニウム塩がクロルヒドロキシアルミニウム、クロルヒドロキシアルミニウム/ジルコニウム、硫酸アルミニウムアンモニウムから選ばれる少なくとも1種である上記(1)記載のデオドラント組成物。
(3) 更に、クジンフラボノイドを含有する請求項1又は2に記載のデオドラント組成物。
(4) エアゾール剤型デオドラント組成物である上記(1)〜(3)の何れか一つに記載のデオドラント組成物。
That is, the present invention resides in the following (1) to (4).
(1) A deodorant composition comprising the following A component and B component.
A component: 0.1-10 mass% of water-soluble hydroxycarboxylic acid chosen from a citric acid, malic acid, and tartaric acid, and 5-40 mass% of water-soluble aluminum salts
B component: 1-10 mass% isostearic acid
(2) The deodorant composition according to the above (1), wherein the water-soluble aluminum salt of the component A is at least one selected from chlorohydroxyaluminum, chlorohydroxyaluminum / zirconium, and aluminum ammonium sulfate.
(3) The deodorant composition according to claim 1 or 2, further comprising a kudin flavonoid.
(4) The deodorant composition according to any one of (1) to (3), which is an aerosol type deodorant composition.
本発明によれば、防臭効果に優れ、かつその持続性にも優れたデオドラント組成物が提供される。 ADVANTAGE OF THE INVENTION According to this invention, the deodorant composition excellent in the deodorizing effect and excellent in the sustainability is provided.
以下に、本発明の実施の形態を詳しく説明する。
本発明のデオドラント組成物は、第1発明として、水溶性のヒドロキシカルボン酸及び/又は水溶性のアルミニウム塩〔(A)成分〕と、常温で液体の脂肪酸〔(B)成分〕とを含有することを特徴とするものであり、第2発明は、実質的に溶解していないクエン酸、リンゴ酸、酒石酸、コハク酸、フマル酸から選ばれる少なくとも1種の有機酸を含有し、かつ、非水系であることを特徴とするものである。
以下において、「本発明」というときは、上記第1発明及び第2発明の両方を含む意味である。
Hereinafter, embodiments of the present invention will be described in detail.
The deodorant composition of the present invention contains, as the first invention, a water-soluble hydroxycarboxylic acid and / or a water-soluble aluminum salt [component (A)] and a fatty acid [component (B)] that is liquid at room temperature. The second invention contains at least one organic acid selected from citric acid, malic acid, tartaric acid, succinic acid, and fumaric acid, which is not substantially dissolved, and non-soluble. It is characterized by being aqueous.
In the following, the term “present invention” includes both the first invention and the second invention.
本第1発明で用いる(A)成分は、水溶性のヒドロキシカルボン酸及び/又は水溶性のアルミニウム塩であることが必要である。
用いることができる水溶性のヒドロキシカルボン酸としては、例えば、クエン酸、リンゴ酸、酒石酸、乳酸、グリコール酸、グリセリン酸、サリチル酸などが挙げられる。
これらの中でも、特に、2価以上の水溶性ヒドロキシカルボン酸が刺激性が少ないという点から望ましい。
2価以上の水溶性ヒドロキシカルボン酸としては、例えば、クエン酸、リンゴ酸、酒石酸などが挙げられる。
The component (A) used in the first invention needs to be a water-soluble hydroxycarboxylic acid and / or a water-soluble aluminum salt.
Examples of the water-soluble hydroxycarboxylic acid that can be used include citric acid, malic acid, tartaric acid, lactic acid, glycolic acid, glyceric acid, and salicylic acid.
Among these, a divalent or higher water-soluble hydroxycarboxylic acid is particularly desirable from the viewpoint of low irritation.
Examples of the divalent or higher water-soluble hydroxycarboxylic acid include citric acid, malic acid, and tartaric acid.
また、用いることができる水溶性のアルミニウム塩としては、例えば、塩化アルミニウム、硫酸アルミニウム、クロルヒドロキシアルミニウム、ブロモヒドロキシアルミニウム、クロルヒドロキシアルミニウム/ジルコニウム、硫酸アルミニウムアンモニウムなどが挙げられる。
これらの中でも、特に、クロルヒドロキシアルミニウム、クロルヒドロキシアルミニウム/ジルコニウム、硫酸アルミニウムアンモニウムが刺激性が少ないという点から望ましい。
本発明において上記(A)成分は、1種または2種以上を組み合わせて用いることができる。
Examples of water-soluble aluminum salts that can be used include aluminum chloride, aluminum sulfate, chlorohydroxyaluminum, bromohydroxyaluminum, chlorohydroxyaluminum / zirconium, and aluminum ammonium sulfate.
Among these, chlorohydroxyaluminum, chlorohydroxyaluminum / zirconium, and aluminum ammonium sulfate are particularly desirable from the viewpoint of low irritation.
In the present invention, the component (A) can be used alone or in combination of two or more.
これらの(A)成分のうち、水溶性のヒドロキシカルボン酸を単独で又は併用する場合、その含有量は、デオドラント組成物全量(但し、エアゾール組成物中では噴射剤を除く原液組成物全量、以下同様)に対して、0.1〜10質量%(以下、単に「%」という)とすることが好ましく、更に好ましくは、0.1〜5%とすることが望ましい。
この水溶性のヒドロキシカルボン酸の含有量が、0.1%未満であると、pHを下げるのに十分な効果が得られず、10%を超えると、皮膚のpHが下がりすぎることによる皮膚刺激が懸念される。
また、上記(A)成分のうち、水溶性のアルミニウム塩を単独で又は併用で用いる場合、その含有量は、デオドラント組成物全量に対して、5〜40%とすることが好ましく、更に好ましくは、5〜30%とすることが望ましい。
この水溶性のアルミニウム塩の含有量が、5%未満であると、制汗剤として十分な効果が得られず、40%を超えると、べたつき等の使用感触の低下、皮膚刺激等の懸念がある。
Among these components (A), when a water-soluble hydroxycarboxylic acid is used alone or in combination, the content is the total amount of the deodorant composition (however, the total amount of the stock solution excluding the propellant in the aerosol composition, Similarly, it is preferably 0.1 to 10% by mass (hereinafter simply referred to as “%”), and more preferably 0.1 to 5%.
If the content of the water-soluble hydroxycarboxylic acid is less than 0.1%, a sufficient effect for lowering the pH cannot be obtained, and if it exceeds 10%, the skin irritation due to excessive decrease in the pH of the skin. Is concerned.
In addition, when the water-soluble aluminum salt is used alone or in combination among the components (A), the content is preferably 5 to 40%, more preferably, based on the total amount of the deodorant composition. 5 to 30% is desirable.
When the content of the water-soluble aluminum salt is less than 5%, a sufficient effect as an antiperspirant cannot be obtained, and when it exceeds 40%, there is a concern that the feeling of use such as stickiness may be reduced and skin irritation may occur. is there.
本発明で用いる(B)成分は、常温(25℃、以下同様)で液体の脂肪酸であることが必要である。
用いることができる常温で液体の脂肪酸としては、例えば、イソステアリン酸、オレイン酸、リノール酸、リノレン酸などが挙げられる。
これらの中でも、ニオイの点などからイソステアリン酸が好ましい。
本発明において上記(B)成分は、1種または2種以上を組み合わせて用いることができる。
The component (B) used in the present invention needs to be a fatty acid that is liquid at room temperature (25 ° C., the same applies hereinafter).
Examples of fatty acids that are liquid at room temperature include isostearic acid, oleic acid, linoleic acid, and linolenic acid.
Among these, isostearic acid is preferable from the viewpoint of odor.
In the present invention, the component (B) can be used alone or in combination of two or more.
これらの(B)成分である常温で液体の脂肪酸の含有量は、デオドラント組成物全量に対して、1〜10%とすることが好ましく、更に好ましくは、1〜7%とすることが望ましい。
この(B)成分の含有量が1%未満であると、pHを維持するのに十分な効果が得られず、また、10%を超えると、脂肪酸の皮膚への刺激が懸念される。
The content of these fatty acids which are liquid at room temperature as the component (B) is preferably 1 to 10%, more preferably 1 to 7%, based on the total amount of the deodorant composition.
If the content of the component (B) is less than 1%, a sufficient effect for maintaining the pH cannot be obtained, and if it exceeds 10%, there is a concern about fatty acid irritation to the skin.
本第1発明のデオドラント組成物には、上記(A)成分及び(B)成分の他に、本発明の効果を損なわない範囲で、デオドラント組成物に常用されている各成分(任意成分)を含有することができる。
本発明に用いることができる任意成分としては、例えば、油脂類、ワックス類、シリコーン類、酸化防止剤、有機粉体、無機粉体、界面活性剤、香料、防腐剤、紫外線吸収剤、キレート剤、保湿剤、増粘剤、清涼剤、殺菌剤、抗炎症剤、アミノ酸、植物エキス、包接化合物等が挙げられる。
具体的には、ナイロン末、ポリエチレン末、無水ケイ酸、シリコーンパウダー、セルロース粉体、タルク、カオリン、マイカ等の使用性向上粉体、多孔質マグネシアシリカ粉体、合成層状ピロケイ酸酸マグネシウム粉体、アルギン酸カルシウム粉体(2次凝集物)、アパタイト粉体等の消臭粉体、メチルパラベン、エチルパラベン、安息香酸ナトリウム、エタノール類等の防腐剤、ベントナイト、グリチルレチン酸ステアリル等の皮膚保護剤、グリセリン、ヒアルロン酸、尿素等の保湿剤、アロエエキス、ユーカリエキス、クワエキス、シラカバエキス等の植物抽出エキス、ヒドロキシプロピルセルロース、ヒドロキシメチルセルロース等の粘度調整剤、ウロカニン酸、パラアミノ安息香酸、パラメトキシケイ皮酸イソプロピル、ヒドロキシメトキシベンゾフェノン等の紫外線吸収剤、トコフェノール等の抗酸化剤、顔料、香料等が挙げられる。
In addition to the components (A) and (B), the deodorant composition of the first invention includes components (arbitrary components) commonly used in the deodorant composition within a range not impairing the effects of the present invention. Can be contained.
Examples of optional components that can be used in the present invention include fats and oils, waxes, silicones, antioxidants, organic powders, inorganic powders, surfactants, fragrances, preservatives, ultraviolet absorbers, and chelating agents. , Moisturizers, thickeners, cooling agents, bactericides, anti-inflammatory agents, amino acids, plant extracts, inclusion compounds and the like.
Specifically, nylon powder, polyethylene powder, silicic anhydride, silicone powder, cellulose powder, talc, kaolin, mica, and other usability improving powders, porous magnesia silica powder, synthetic layered magnesium pyrosilicate powder , Deodorizing powder such as calcium alginate powder (secondary aggregate), apatite powder, antiseptic such as methylparaben, ethylparaben, sodium benzoate, ethanol, skin protective agent such as bentonite, stearyl glycyrrhetinate, glycerin , Moisturizers such as hyaluronic acid and urea, plant extract extracts such as aloe extract, eucalyptus extract, mulberry extract, birch extract, viscosity modifiers such as hydroxypropylcellulose, hydroxymethylcellulose, urocanic acid, paraaminobenzoic acid, paramethoxycinnamic acid Isopropyl, hydroxy Butoxy ultraviolet absorbers such as benzophenone, antioxidants tocopherol etc., pigments, perfumes and the like.
本第1発明のデオドラント組成物は、用途に併せてロールオンタイプ、ミストスプレータイプ、ローションタイプ、クリームタイプ、シートタイプ、泡状タイプ、液状タイプ、スチィックタイプ、エアゾールタイプなどの形態をとることができるが、これらに限定されるものではない。
使用上の簡便性及び清潔性等の点から、エアゾール型とすることが好ましく、このエアゾール型とする場合には、噴射剤として、プロパン、イソブタン、ノルマルブタン、イソペンタン、ネオペンタン等の炭化水素系ガス(LPG)、及び、ジメチルエーテル(DME)等の液化ガスなどを用いることができる。これらに加えて、炭酸ガス、窒素ガスを用いてもよい。上記の噴射剤は、それぞれ単独で、または2種類以上を混合して使用することができる。
The deodorant composition of the first invention can take forms such as a roll-on type, a mist spray type, a lotion type, a cream type, a sheet type, a foam type, a liquid type, a stick type, and an aerosol type in accordance with the application. However, it is not limited to these.
From the viewpoint of ease of use and cleanliness, it is preferable to use an aerosol type, and in the case of this aerosol type, as a propellant, hydrocarbon gas such as propane, isobutane, normal butane, isopentane, neopentane, etc. (LPG) and liquefied gas such as dimethyl ether (DME) can be used. In addition to these, carbon dioxide gas and nitrogen gas may be used. Said propellant can be used individually or in mixture of 2 or more types, respectively.
このように構成される第1発明のデオドラント組成物では、(A)成分である水溶性のヒドロキシカルボン酸及び/又は水溶性のアルミニウム塩で即効的に汗や皮膚表面のpHを低くし菌の生育を阻止せしめ、更に(B)成分の水に難溶な常温で液体の脂肪酸の併用により、その脂肪酸が徐々に溶解することで、肌上で徐々に溶けてそのpH(酸性)を長期間維持できることとなる。その結果、皮膚常在菌の増殖を長時間抑えることにより、持続性のある皮膚用等に好適なデオドラント組成物が得られることとなる。 In the deodorant composition of the first invention constituted as described above, the water-soluble hydroxycarboxylic acid and / or the water-soluble aluminum salt as the component (A) can immediately lower the pH of sweat or skin surface and effectively reduce the fungus. Growth is inhibited, and the fatty acid is gradually dissolved by the combined use of a fatty acid which is hardly soluble in water of component (B) at room temperature, so that it gradually dissolves on the skin and maintains its pH (acidity) for a long time. It can be maintained. As a result, it is possible to obtain a deodorant composition suitable for long-lasting skin and the like by suppressing the growth of skin resident bacteria for a long time.
次に、本第2発明のデオドラント組成物は、実質的に溶解していないクエン酸、リンゴ酸、酒石酸、コハク酸、フマル酸から選ばれる少なくとも1種の有機酸を含有し、かつ、非水系であることを特徴とするものである。
本第2発明に用いるクエン酸、リンゴ酸、酒石酸、コハク酸、フマル酸から選ばれる有機酸は、防臭効果の更なる持続性の点から、組成物中に粉体として含有されるものである。
なお、本第2発明で用いるクエン酸は、無水クエン酸、クエン酸1水和物どちらもでもよいが、吸湿の面から無水クエン酸の方が好ましい。
Next, the deodorant composition of the second invention contains at least one organic acid selected from citric acid, malic acid, tartaric acid, succinic acid, and fumaric acid that is not substantially dissolved, and is non-aqueous. It is characterized by being.
The organic acid selected from citric acid, malic acid, tartaric acid, succinic acid, and fumaric acid used in the second invention is contained as a powder in the composition from the viewpoint of further sustaining the deodorizing effect. .
The citric acid used in the second invention may be either anhydrous citric acid or citric acid monohydrate, but anhydrous citric acid is preferred in terms of moisture absorption.
これらの有機酸の平均粒子径は、好ましくは、1〜75μm、更に好ましくは、1〜45μmとすることが望ましい。
この平均粒子径が75μmを越えると、エアゾールスプレーから内容物を噴射したときに、噴霧不良を起こしたり、肌に当たったときに痛みを感じたりしてしまうことがある。なお、平均粒子径が1μm未満の場合は、有機酸の破砕に時間がかかり、好ましくない。
これら有機酸を微粉化する方法としては、例えば、スプレードライ法、粉砕が挙げられる。粉砕は、乳鉢にてすりつぶしても得られるが、ボールミル、スパイラルミル、ジェットミル、摩砕機等の機械を使用して得ることができる。
The average particle diameter of these organic acids is preferably 1 to 75 μm, and more preferably 1 to 45 μm.
If the average particle diameter exceeds 75 μm, spraying of the contents from the aerosol spray may cause poor spraying or may cause pain when hitting the skin. In addition, when an average particle diameter is less than 1 micrometer, it takes time for crushing of an organic acid, and is not preferable.
Examples of a method for pulverizing these organic acids include spray drying and pulverization. Although pulverization can be obtained by grinding in a mortar, it can be obtained using a machine such as a ball mill, a spiral mill, a jet mill, or a grinder.
上記有機酸粉体の含有量は、デオドラント組成物全量に対して、好ましくは、0.1〜10%、更に好ましくは、0.1〜5%とすることが望ましい。
この有機酸粉体の含有量が0.1%未満であると、効果が乏しく、また、10%を越えて含有すると、皮膚のpHが極端に酸性となり、中には皮膚刺激を伴う場合がある。
The content of the organic acid powder is preferably 0.1 to 10%, more preferably 0.1 to 5%, based on the total amount of the deodorant composition.
When the content of the organic acid powder is less than 0.1%, the effect is poor, and when the content exceeds 10%, the pH of the skin becomes extremely acidic, and there may be skin irritation in some cases. is there.
本第2発明のデオドラント組成物は、防臭効果の持続性を更に長時間延ばす点から、非水系とするものであり、非水系であれば、特に限定されず、エアゾールタイプ、ステックタイプ、油性ゲルタイプなどにより非水系とすることができる。 The deodorant composition of the second aspect of the present invention is non-aqueous from the point of extending the durability of the deodorizing effect for a long time, and is not particularly limited as long as it is non-aqueous. Aerosol type, stick type, oily gel It can be non-aqueous depending on the type.
本第2発明のデオドラント組成物には、上記各成分の他に、本発明の効果を損なわない範囲で、デオドラント組成物に常用されている上述の各成分(任意成分)を含有することができる。
また、本第2発明のデオドラント組成物は、非水系であるので、エアゾールタイプ、ステックタイプ、油性ゲルタイプなどの形態をとることができる。エアゾール型とする場合には、噴射剤として、上述の各噴射剤を用いることができる。
特に、本題2発明のデオドラント組成物は、使用上の簡便性及び清潔性等の点から、非水系のエアゾール型とすることが好ましい。
The deodorant composition of the second invention can contain the above-mentioned components (arbitrary components) commonly used in the deodorant composition within the range not impairing the effects of the present invention, in addition to the above-described components. .
Moreover, since the deodorant composition of this 2nd invention is a non-aqueous system, it can take forms, such as an aerosol type, a stick type, and an oil-based gel type. When the aerosol type is used, each of the above-described propellants can be used as the propellant.
In particular, the deodorant composition of the present invention 2 is preferably a non-aqueous aerosol type from the viewpoint of ease of use and cleanliness.
このように構成される本第2発明のデオドラント組成物は、非水系であり、クエン酸、リンゴ酸、酒石酸、コハク酸、フマル酸から選ばれる少なくとも1種の有機酸は粉体として存在し、この組成物を、例えば、エアゾールスプレータイプで用いると、非水系のエアゾール中でクエン酸等の有機酸は粉体として存在し、スプレーすると、クエン酸等は粉体(固体)のまま肌につき、汗等肌上の水分で溶解し、肌面のpHを下げて菌の生育を阻止し、その防臭効果を長時間に亘り発揮するものである。なお、予め溶解している有機酸の場合は、pHを即効的に下げるものであるが、本第2発明の場合は、持続性の面で更に優れた持続的防臭効果を発揮するものである。 The deodorant composition of the present invention thus configured is non-aqueous, and at least one organic acid selected from citric acid, malic acid, tartaric acid, succinic acid, and fumaric acid exists as a powder, When this composition is used in, for example, an aerosol spray type, an organic acid such as citric acid is present as a powder in a non-aqueous aerosol, and when sprayed, the citric acid and the like remain in powder (solid) on the skin. It dissolves with moisture on the skin such as sweat, lowers the pH of the skin surface to inhibit the growth of bacteria, and exhibits its deodorizing effect for a long time. In addition, in the case of an organic acid dissolved in advance, the pH is immediately lowered, but in the case of the second invention, it exhibits a further excellent deodorizing effect in terms of sustainability. .
本発明(上記第1発明及び第2発明)のデオドラント組成物は、上述の如く、防臭効果に優れ、かつその持続性にも優れたものであるが、更なる防臭効果、並びに、その持続性を更に相乗的に向上せしめる点から、クジン抽出物等が得られるクジンフラボノイドを含有せしめることが好ましい。 The deodorant composition of the present invention (the first invention and the second invention) is excellent in deodorizing effect and excellent in its sustainability as described above, but has a further deodorizing effect and its sustainability. From the point of further improving the synergisticity, it is preferable to contain a kudin flavonoid from which a kudin extract or the like can be obtained.
用いるクジンフラボノイドは、弱酸性を示すことから、クエン酸等と同様にpHの低下に寄与するものとなる。更に、殺菌作用がある。このため、クジンフラボノイドを上記第1発明及び第2発明のデオドラント組成物に含有せしめると、更に菌の増殖を相乗的に抑え、防臭効果、特にその持続性が更に向上することとなる。
このクジンフラボノイドの含有量は、デオドラント組成物全量に対して、0.0001〜10%、更に好ましくは、0.001〜5%とすることが望ましい。
このクジンフラボノイドの含有量が0.0001%未満であると、更なる効果を発揮することができず、10%を越えて含有すると、フラボノイド特有の着色が製品の外観を損ねることがある。
Since the kudin flavonoid to be used shows weak acidity, it contributes to the fall of pH like citric acid etc. Furthermore, it has a bactericidal action. For this reason, when a kudin flavonoid is included in the deodorant composition of the first invention and the second invention, the growth of bacteria is further suppressed in a synergistic manner, and the deodorizing effect, particularly its sustainability, is further improved.
The content of this kudin flavonoid is 0.0001 to 10%, more preferably 0.001 to 5%, based on the total amount of the deodorant composition.
If the content of this kudin flavonoid is less than 0.0001%, a further effect cannot be exhibited, and if it exceeds 10%, the coloration peculiar to the flavonoid may impair the appearance of the product.
次に、実施例及び比較例を挙げて本発明をより具体的に説明するが、本発明は下記実施例に制限されるものではない。なお、以下の表中の%は、質量%であり、全量100%である。 EXAMPLES Next, although an Example and a comparative example are given and this invention is demonstrated more concretely, this invention is not restrict | limited to the following Example. In addition,% in the following table | surface is the mass% and is 100% of the whole quantity.
〔実施例1〜4及び比較例1〜4、並びに参考例(第1発明)〕
下記表1に示す配合組成(原液)となるエアゾールタイプの皮膚用のデオドラント組成物を調製した。
得られたデオドラント組成物について、下記各方法により、皮膚pH、防臭効果について評価した。
これらの結果を下記表1に示す。
[Examples 1-4 and Comparative Examples 1-4, and Reference Example (first invention)]
An aerosol-type skin deodorant composition having the composition (stock solution) shown in Table 1 below was prepared.
About the obtained deodorant composition, skin pH and the deodorizing effect were evaluated by the following methods.
These results are shown in Table 1 below.
(皮膚pHの測定法)
男女被験者20名の腋窩部に試料を適量塗布し、塗布直後、4時間後、8時間後の腋のpHをpHメーター(堀場製作所社製 pHメーターD-21)にて測定した。なお、エアゾールタイプの場合は、2秒間噴霧した。
(Measurement method of skin pH)
An appropriate amount of a sample was applied to the axilla of 20 male and female subjects, and the pH of the eyelids was measured immediately after application, 4 hours, and 8 hours later with a pH meter (pH meter D-21, manufactured by Horiba, Ltd.). In the case of an aerosol type, spraying was performed for 2 seconds.
(防臭効果の評価法)
上記、男女被験者20名の片方の腋窩部に試料を適量塗布し、もう片方の腋には何も処理せず、その後、予め洗浄したガーゼを腋窩部に縫い付けたシャツを10名の被験者には4時間、残りの10名の被験者は8時間、着用してもらった。
ガーゼに付着した体臭を、専門パネラーが下記評価基準に基づいて官能評価した。なお、エアゾールタイプの場合は、2秒間噴霧した。
<評価基準>
3点:無塗布部よりも非常に良い(臭わない)
2点:無塗布部よりもかなり良い(臭わない)
1点:無塗布部よりもやや良い(臭わない)
0点:無塗布部と同等
◎:10人の被験者の平均点が2.5点以上
○:10人の被験者の平均点が2点以上
△:10人の被験者の平均点が1点以上2点未満
×:10人の被験者の平均点が1点未満
(Evaluation method of deodorizing effect)
Apply the appropriate amount of sample to one axilla part of 20 male and female subjects, do not treat anything on the other axilla, and then put 10 shirts sewn with pre-washed gauze on the axilla part. Was worn for 4 hours and the remaining 10 subjects were worn for 8 hours.
A specialized panelist sensory-evaluated the body odor adhering to the gauze based on the following evaluation criteria. In the case of an aerosol type, spraying was performed for 2 seconds.
<Evaluation criteria>
3 points: Very better than the uncoated part (no odor)
2 points: considerably better than the uncoated part (no odor)
1 point: Slightly better than uncoated area (no odor)
0 point: Equivalent to the uncoated part ◎: Average score of 10 subjects is 2.5 or more ○: Average score of 10 subjects is 2 or more Δ: Average score of 10 subjects is 1 or more 2 Less than point ×: The average score of 10 subjects is less than 1 point
上記表1の結果から明らかなように、エアゾールタイプのデオドラント組成物において、本発明の範囲となる実施例1〜4は、本発明の範囲外の比較例1〜4に較べて、防臭効果に優れ、かつその持続性にも優れていることが判明した。 As is clear from the results of Table 1 above, in the aerosol type deodorant composition, Examples 1 to 4 within the scope of the present invention are more effective in deodorizing than Comparative Examples 1 to 4 outside the scope of the present invention. It was found to be excellent and durable.
〔実施例5〜8及び比較例5〜7、第1発明〕
下記表2及び表3に示す配合組成(原液)となるスティックタイプの皮膚用のデオドラント組成物(実施例5〜6、比較例5〜6)、ロールオンタイプの皮膚用のデオドラント組成物(実施例7〜8、比較例7)を調製した。
得られたデオドラント組成物について、上記各方法により、皮膚pH、防臭効果について評価した。
これらの結果を下記表2及び表3に示す。
[Examples 5 to 8 and Comparative Examples 5 to 7, first invention]
Deodorant compositions for stick-type skin (Examples 5-6, Comparative Examples 5-6) to be the composition (stock solution) shown in Table 2 and Table 3 below, deodorant compositions for roll-on skin (Examples) 7-8, Comparative Example 7) were prepared.
About the obtained deodorant composition, skin pH and the deodorizing effect were evaluated by said each method.
These results are shown in Tables 2 and 3 below.
上記表2及び3の結果から明らかなように、スチィックタイプ、ロールオンタイプのデオドラント組成物において、本発明の範囲となる実施例5〜8は、本発明の範囲外の比較例5〜7に較べて、防臭効果に優れ、かつその持続性にも優れていることが判明した。 As is clear from the results of Tables 2 and 3 above, in the stick-type and roll-on type deodorant compositions, Examples 5 to 8 which are within the scope of the present invention are compared with Comparative Examples 5 to 7 outside the scope of the present invention. In comparison, it was found that the deodorizing effect was excellent and the sustainability was also excellent.
〔実施例9及び比較例8〜9(第2発明)〕
下記表4に示す有機酸粉体(各平均粒子径)を含有する配合組成(原液)のエアゾールタイプの皮膚用のデオドラント組成物を調製した。
得られたデオドラント組成物について、上記各方法により、皮膚pH、防臭効果について評価した。
これらの結果を下記表4に示す。
[Example 9 and Comparative Examples 8 to 9 (second invention)]
An aerosol-type deodorant composition for skin having a composition (stock solution) containing organic acid powders (each average particle diameter) shown in Table 4 below was prepared.
About the obtained deodorant composition, skin pH and the deodorizing effect were evaluated by said each method.
These results are shown in Table 4 below.
上記表4の結果から明らかなように、エアゾールタイプのデオドラント組成物において、本発明の範囲となる実施例9は、本発明の範囲外の比較例8〜9に較べて、防臭効果に優れ、かつその持続性にも優れていることが判明した。 As is clear from the results of Table 4 above, in the aerosol type deodorant composition, Example 9 which is within the scope of the present invention has an excellent deodorizing effect as compared with Comparative Examples 8 to 9 outside the scope of the present invention. It was also found that the durability was excellent.
〔実施例10〜15(第2発明)〕
下記表5に示す有機酸粉体(各平均粒子径)を含有する配合組成(原液)の非水系エアゾールタイプの皮膚用のデオドラント組成物を調製した。
得られたデオドラント組成物について、上記各方法により、皮膚pH、防臭効果について評価した。
これらの結果を下記表5に示す。
[Examples 10 to 15 (second invention)]
A non-aqueous aerosol type deodorant composition for skin having a composition (stock solution) containing organic acid powders (each average particle size) shown in Table 5 below was prepared.
About the obtained deodorant composition, skin pH and the deodorizing effect were evaluated by said each method.
These results are shown in Table 5 below.
上記表5の結果から明らかなように、非水系エアゾールタイプのデオドラント組成物となる本発明の実施例10〜15は、防臭効果に優れ、かつその持続性にも優れていることが判明した。 As is clear from the results in Table 5 above, it was found that Examples 10 to 15 of the present invention, which are non-aqueous aerosol type deodorant compositions, were excellent in deodorizing effect and excellent in sustainability.
Claims (4)
A成分:クエン酸、リンゴ酸、酒石酸から選ばれる水溶性のヒドロキシカルボン酸0.1〜10質量%及び水溶性のアルミニウム塩5〜40質量%
B成分:イソステアリン酸1〜10質量% The deodorant composition characterized by containing the following A component and B component.
A component: 0.1-10 mass% of water-soluble hydroxycarboxylic acid chosen from a citric acid, malic acid, and tartaric acid, and 5-40 mass% of water-soluble aluminum salts
B component: 1-10 mass% isostearic acid
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003366253A JP4293883B2 (en) | 2003-03-17 | 2003-10-27 | Deodorant composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003071307 | 2003-03-17 | ||
JP2003366253A JP4293883B2 (en) | 2003-03-17 | 2003-10-27 | Deodorant composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004300132A JP2004300132A (en) | 2004-10-28 |
JP4293883B2 true JP4293883B2 (en) | 2009-07-08 |
Family
ID=33421728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003366253A Expired - Fee Related JP4293883B2 (en) | 2003-03-17 | 2003-10-27 | Deodorant composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4293883B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7515355B2 (en) | 2020-09-18 | 2024-07-12 | 株式会社Lixil | Fittings |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080206351A1 (en) * | 2007-02-23 | 2008-08-28 | Conopco, Inc., D/B/A Unilever | Malodor Reduction of Cosmetic Products |
JP6118089B2 (en) * | 2012-12-05 | 2017-04-19 | 花王株式会社 | Cosmetic composition |
-
2003
- 2003-10-27 JP JP2003366253A patent/JP4293883B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7515355B2 (en) | 2020-09-18 | 2024-07-12 | 株式会社Lixil | Fittings |
Also Published As
Publication number | Publication date |
---|---|
JP2004300132A (en) | 2004-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0892011A (en) | Deodorizing make-up goods | |
JP2003012511A (en) | Aerosol composition | |
US10576309B2 (en) | Method of reducing perspiration | |
JP2004352688A (en) | Antiseptic agent | |
US20200078276A1 (en) | Antiperspirant | |
JP3908244B2 (en) | Male deodorant deodorant | |
EP3946223B1 (en) | Antiperspirant and deodorant compositions | |
JP4293883B2 (en) | Deodorant composition | |
JP2018521099A (en) | Cosmetic formulations that reduce sweat | |
JP2005350357A (en) | Body smell-preventing cosmetic | |
US20200078277A1 (en) | Sweat-reducing cosmetic preparation | |
JP2010116376A (en) | Cosmetic | |
JP2006298804A (en) | Aerosol composition | |
JP3905512B2 (en) | Aerosol composition | |
ES2180439B2 (en) | COSMETIC-DERMATOLOGICAL COMPOSITION. | |
JP2006335761A (en) | Sustained release deodorizing composition | |
US20180228705A1 (en) | Antiperspirant | |
JP2018521100A (en) | Antiperspirant | |
AU2016299200A1 (en) | Antiperspirant | |
WO2019084634A1 (en) | Antiperspirant deodorant gel | |
JP2005289953A (en) | ANTIBACTERIAL AGENT COMPRISING METHYL p-HYDROXYBENZOATE AS ACTIVE INGREDIENT AND EXTERNAL COMPOSITION COMPRISING THE SAME | |
JP2006143636A (en) | Makeup foundation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060803 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20080117 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080219 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080418 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090407 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090407 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120417 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4293883 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130417 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130417 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140417 Year of fee payment: 5 |
|
LAPS | Cancellation because of no payment of annual fees |